Drug Type Monoclonal antibody |
Synonyms- |
Target |
Mechanism ROBO1 inhibitors(Roundabout homolog 1 inhibitors), ROBO2 antagonists(roundabout guidance receptor 2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neovascularization, Pathologic | Preclinical | US | 20 Nov 2024 |